Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Mouse genital development depends on male or female hormones for specific features.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Estrogens and progesterone are key in regulating melasma pigmentation.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.